Mayne Pharma Group Ltd.ASX: MYX

Update on Scheme and Supreme Court of NSW proceedings

· Issued by Mayne Pharma Group Ltd.

Filed with ASX · · 2 pages · English

Summary by 6ix AI

Mayne Pharma Group Ltd. provides an update on its proposed acquisition by Cosette Pharmaceuticals and ongoing legal proceedings in the Supreme Court of New South Wales regarding the termination of the Scheme Implementation Deed. The court previously ruled in favor of Mayne Pharma, dismissing Cosette's claims, but Cosette has filed a notice of intention to appeal. Mayne Pharma is committed to implementing the acquisition scheme, pending certain approvals and a scheduled court hearing. The company will keep the market informed of any changes to the timetable related to the acquisition process.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Mayne Pharma Group Ltd. on 6ix

Story so far

Earlier from Mayne Pharma

Later from Mayne Pharma

All Mayne Pharma news releases